Alpha 2.0
Login Register
» Authors » Jarno Riikonen

Jarno Riikonen

Explore the profile of Jarno Riikonen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 31
Citations 357
Followers 0
Related Specialties
Urology
General Medicine
Psychiatry
Top 10 Co-Authors
Antti Kaipia
Teemu J Murtola
Peter J Bostrom
Antti Rannikko
Juha Koskimaki
Otto Ettala
Marjo Seppanen
Juha Knaapila
Ivan Jambor
Tuomas Mirtti
Published In
Scand J Urol
Eur Urol
BJU Int
J Magn Reson Imaging
J Urol
Affiliations
Soon will be listed here.
Recent Articles
1.
Prostate Cancer Screening With PSA, Kallikrein Panel, and MRI: The ProScreen Randomized Trial
Auvinen A, Tammela T, Mirtti T, Lilja H, Tolonen T, Kenttamies A, et al.
JAMA . 2024 Apr; 331(17):1452-1459. PMID: 38581254
Importance: Prostate-specific antigen (PSA) screening has potential to reduce prostate cancer mortality but frequently detects prostate cancer that is not clinically important. Objective: To describe rates of low-grade (grade group...
2.
Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: prospects for personalized medicine
Nurminen A, Jaatinen S, Taavitsainen S, Hognas G, Lesluyes T, Ansari-Pour N, et al.
Genome Med . 2023 Oct; 15(1):82. PMID: 37828555
Background: Prostate cancer (PrCa) genomic heterogeneity causes resistance to therapies such as androgen deprivation. Such heterogeneity can be deciphered in the context of evolutionary principles, but current clinical trials do...
3.
Robot-assisted versus three-dimensional laparoscopic radical prostatectomy: 12-month outcomes of a randomised controlled trial
Haapiainen H, Murtola T, Koskimaki J, Riikonen J, Pakarainen T, Haney C, et al.
BJU Int . 2023 Jul; 132(5):505-511. PMID: 37461186
Objectives: To compare functional and oncological outcomes of robot-assisted laparoscopic prostatectomy (RALP) to three-dimensional laparoscopic radical prostatectomy (3D-LRP) at 12 months after surgery. Patients And Methods: Prospective randomised single-centre study...
4.
Randomised double-blind phase 3 clinical study testing impact of atorvastatin on prostate cancer progression after initiation of androgen deprivation therapy: study protocol
Siltari A, Riikonen J, Koskimaki J, Pakarainen T, Ettala O, Bostrom P, et al.
BMJ Open . 2022 Apr; 12(4):e050264. PMID: 35487730
Introduction: Blood cholesterol is likely a risk factor for prostate cancer prognosis and use of statins is associated with lowered risk of prostate cancer recurrence and progression. Furthermore, use of...
5.
Detection of Prostate Cancer Using Biparametric Prostate MRI, Radiomics, and Kallikreins: A Retrospective Multicenter Study of Men With a Clinical Suspicion of Prostate Cancer
Montoya Perez I, Merisaari H, Jambor I, Ettala O, Taimen P, Knaapila J, et al.
J Magn Reson Imaging . 2021 Jul; 55(2):465-477. PMID: 34227169
Background: Accurate detection of clinically significant prostate cancer (csPCa), Gleason Grade Group ≥ 2, remains a challenge. Prostate MRI radiomics and blood kallikreins have been proposed as tools to improve...
6.
Preservation of Endopelvic Fascia: Effects on Postoperative Incontinence and Sexual Function - A Randomized Clinical Trial
Siltari A, Riikonen J, Murtola T
J Sex Med . 2020 Dec; 18(2):327-338. PMID: 33358241
Background: Urinary incontinence and sexual dysfunction are common after robot-assisted radical prostatectomy (RALP). New surgical techniques to improve these functions after the operation are under evaluation for example, preservation of...
7.
Circulatory and prostatic tissue lipidomic profiles shifts after high-dose atorvastatin use in men with prostate cancer
Raittinen P, Niemisto K, Pennanen E, Syvala H, Auriola S, Riikonen J, et al.
Sci Rep . 2020 Jul; 10(1):12016. PMID: 32694638
Prostate cancer patients using cholesterol-lowering statins have 30% lower risk of prostate cancer death compared to non-users. The effect is attributed to the inhibition of the mevalonate pathway in prostate...
8.
Urine colour as an indicator for anastomotic leakage after robot-assisted radical prostatectomy
Riikonen J, Pakarainen T, Siltari A, Pienimaki J, Koskimaki J, Murtola T
Scand J Urol . 2020 Apr; 54(3):201-207. PMID: 32308088
To determine whether macroscopic haematuria predicts urethrovesical anastomotic leakage after robot-assisted laparoscopic radical prostatectomy (RALP) as well as a cystogram. Participants were recruited before cystogram and catheter removal 5-14 days...
9.
Qualitative and Quantitative Reporting of a Unique Biparametric MRI: Towards Biparametric MRI-Based Nomograms for Prediction of Prostate Biopsy Outcome in Men With a Clinical Suspicion of Prostate Cancer (IMPROD and MULTI-IMPROD Trials)
Montoya Perez I, Jambor I, Kauko T, Verho J, Ettala O, Falagario U, et al.
J Magn Reson Imaging . 2019 Nov; 51(5):1556-1567. PMID: 31750988
Background: Multiparametric MRI of the prostate has been shown to improve the risk stratification of men with an elevated prostate-specific antigen (PSA). However, long acquisition time, high cost, and inter-center/reader...
10.
Effects of Preoperative Atorvastatin Treatment On Erectile Function After Radical Prostatectomy: Results From a Subgroup of ESTO1, a Randomized, Double-Blind, Placebo-Controlled Study
Siltari A, Riikonen J, Fode M, Murtola T
J Sex Med . 2019 Aug; 16(10):1597-1605. PMID: 31405764
Introduction: Erectile dysfunction is common after radical prostatectomy because of damage to the cavernous nerves. Thus, it is important to identify new ways to avoid this problem. For example, statins...